Developments like these are where the future of food biotechnology lies (HT: Tyler Cowen):
Researchers have developed a genetically modified tomato that produces a certain peptide which will lower the plaque buildup in the arteries of mice. This could also work in humans.
With 2.2% of the rodent’s diet comprised of the GM tomato, the researchers found that the mice had lower levels of blood inflammation, higher activity of the anti-oxidant enzyme paraoxonase, boosted levels of high density lipoproteins, decreased lysophosphatidic acid and less atherosclerotic plaque.
It's hard to know whether something like this could be commercially viable (or even work in humans), but I suspect that there were more developments like these, GMOs would lose the bad rap.